U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614139) titled 'Continuous Glucose Monitoring Alerts, Accuracy, and Patient Outcomes in Adults With Inherited Metabolic Disorders' on May 15.

Brief Summary: The goal of this clinical trial is to learn if a continuous glucose monitor (CGM) with predictive alerts works better than a CGM with standard alerts to prevent low blood sugar (hypoglycemia) in adults with inherited metabolic disorders (IMDs), such as glycogen storage disorders (GSDs) and congenital hyperinsulinism (CH).

The main questions it aims to answer are:

Does a CGM with predictive alerts lower the time spent with low blood sugar compared to a CGM with standard alerts? Do participants ...